What is OGGT?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is OGTT?

OGTT stands for Oral Glucose Tolerance Test, a diagnostic procedure used to evaluate how the body processes glucose by measuring blood glucose levels at specific time intervals after consuming a standardized glucose load. 1

Test Administration and Preparation

The OGTT requires specific patient preparation to ensure accurate results:

  • The patient must fast for 8-14 hours before the test (typically performed in the morning after an overnight fast). 1
  • At least 150 grams of carbohydrate must be consumed daily for 3 days prior to testing to ensure adequate glycogen stores. 1, 2
  • The patient must remain seated throughout the entire test and should not smoke. 1, 2
  • Unlimited physical activity should be maintained in the days leading up to the test. 2

Standard Glucose Loads and Measurement Points

For non-pregnant adults, a 75-gram glucose load is administered, with blood glucose measurements taken at fasting and 2 hours post-ingestion. 1

For pregnant women (gestational diabetes screening), two approaches exist:

One-Step Approach (IADPSG Criteria)

  • Uses a 75-gram glucose load with measurements at fasting, 1-hour, and 2-hour time points. 2
  • Diagnostic thresholds: fasting ≥92 mg/dL, 1-hour ≥180 mg/dL, 2-hour ≥153 mg/dL. 2
  • Identifies approximately 15-20% of pregnant women with gestational diabetes. 2

Two-Step Approach (ACOG-Supported)

  • Initial 50-gram glucose challenge test, followed by 100-gram OGTT if positive. 2, 3
  • Diagnostic thresholds (Carpenter/Coustan): fasting ≥95 mg/dL, 1-hour ≥180 mg/dL, 2-hour ≥155 mg/dL, 3-hour ≥140 mg/dL. 2
  • Identifies approximately 5-6% of pregnant women with gestational diabetes. 2

Diagnostic Criteria for Diabetes

In non-pregnant adults, a 2-hour plasma glucose ≥200 mg/dL (11.1 mmol/L) during OGTT confirms diabetes (must be confirmed on a subsequent day unless unequivocal hyperglycemia is present). 1

For impaired glucose tolerance (IGT), the 2-hour value falls between 140-199 mg/dL (7.8-11.0 mmol/L). 1

Clinical Utility and Limitations

The OGTT is more sensitive than fasting plasma glucose (FPG) for detecting diabetes and pre-diabetes, but it is less reproducible, more costly, and less convenient. 1

For routine clinical practice, FPG is preferred over OGTT due to ease of use, lower cost, and better patient acceptability. 1

However, OGTT may be useful in patients with impaired fasting glucose (IFG) to better define diabetes risk. 1

Important Caveats

  • The test has poor reproducibility, particularly for the 2-hour glucose value (κ statistic of 0.157-0.174, indicating only "slight strength of agreement"). 4
  • Caution should be exercised when interpreting a single positive OGTT result, especially in pregnancy. 4
  • The OGTT is not recommended for routine clinical screening outside of pregnancy due to its practical limitations. 1

Timing for Gestational Diabetes Screening

All pregnant women should be screened at 24-28 weeks of gestation. 2, 3

High-risk women (marked obesity with BMI ≥30 kg/m², personal history of gestational diabetes, glycosuria, or strong family history of diabetes) should undergo glucose testing as early as the first prenatal visit (12-14 weeks). 2, 3

If negative at the first prenatal visit, high-risk women must be retested at 24-28 weeks. 2, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Oral Glucose Tolerance Test in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Gestational Diabetes Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.